Massachusetts Financial Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.6M Sell
431,324
-6,678
-2% -$346K 0.01% 607
2026
Q1
$21.1M Buy
438,002
+12,770
+3% +$566K 0.01% 630
2025
Q4
$17.5M Sell
425,232
-33,072
-7% -$1.33M 0.01% 664
2025
Q3
$17.8M Buy
458,304
+394,072
+614% +$12.8M 0.01% 644
2025
Q2
$1.78M Buy
64,232
+793
+1% +$20.2K ﹤0.01% 774
2025
Q1
$1.41M Sell
63,439
-1,442
-2% -$29.7K ﹤0.01% 782
2024
Q4
$1.28M Sell
64,881
-1,935
-3% -$44.2K ﹤0.01% 795
2024
Q3
$1.67M Sell
66,816
-1,618
-2% -$39.4K ﹤0.01% 749
2024
Q2
$1.28M Sell
68,434
-7,049
-9% -$132K ﹤0.01% 780
2024
Q1
$1.49M Sell
75,483
-167
-0.2% -$3.26K ﹤0.01% 755
2023
Q4
$1.33M Sell
75,650
-2,392
-3% -$39.3K ﹤0.01% 753
2023
Q3
$1.36M Sell
78,042
-2,990
-4% -$50.4K ﹤0.01% 750
2023
Q2
$1.14M Sell
81,032
-1,909
-2% -$25.6K ﹤0.01% 743
2023
Q1
$892K Buy
+82,941
New +$1.09M ﹤0.01% 772

Other funds holding KNSA

Massachusetts Financial Services's KNSA Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Kiniksa Pharmaceuticals (KNSA) stake by 1.5% in Q2 2026, selling an estimated $346K and leaving 431,324 shares worth $27.6M. The position accounts for 0.01% of the portfolio, ranked #607.

Massachusetts Financial Services first reported a position in KNSA in Q1 2023 and has held it in 14 quarters since. 94 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Massachusetts Financial Services held 431,324 shares of Kiniksa Pharmaceuticals worth $27.6M as of Q2 2026.
  • Massachusetts Financial Services sold 6,678 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $346K.
  • Kiniksa Pharmaceuticals made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #607 holding.
  • Massachusetts Financial Services first reported a position in Kiniksa Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 94 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.